Continua AI vs iGEN: Revenue, Funding & Team Size Compared
Continua AI generates $1.2M in revenue; iGEN generates $1.2M. Continua AI and iGEN are close to the same size by revenue. The table below compares Continua AI and iGEN on funding, valuation, customers, team size and headquarters — every figure GetLatka has verified for each company.
| Company | ||
|---|---|---|
| Revenue | $1.2M | $1.2M |
| Funding raised | $8M | Not disclosed |
| Team size | 11 | 11 |
| Founded | 2023 | Not disclosed |
| HQ | New York, United States | United States |
Want the full dataset? GetLatka tracks revenue, funding and team history for thousands of SaaS companies, with charts, growth rates and founder interviews.
Continua AI at a glance
Continua AI generates $1.2M in revenue with 11 employees, headquartered in New York, United States.
- Revenue
- $1.2M
- Funding
- $8M
- Team size
- 11
- Founded
- 2023
We are on a mission to revolutionize how people interact with information, services, and each other. https://www.continua.ai/
iGEN at a glance
iGEN generates $1.2M in revenue with 11 employees, headquartered in United States.
- Revenue
- $1.2M
- Team size
- 11
We take on your innovative business model and extreme engineering requirements and build a core solution for a fraction of the cost of alternatives. And, anticipating future growth, we design this core to be robust and scalable. We take…
Other Continua AI alternatives
Continua AI competes with more than the companies on this page. Browse the full alternative lists to compare revenue, funding and team size across the category.
Continua AI vs iGEN: frequently asked questions
Is Continua AI or iGEN bigger?
Continua AI is the bigger company by revenue, at $1.2M against $1.2M for iGEN.
How much revenue does Continua AI make?
Continua AI generates $1.2M in annual revenue with a team of 11.
How much revenue does iGEN make?
iGEN generates $1.2M in annual revenue with a team of 11.
How much funding has Continua AI raised?
Continua AI has raised $8M in total funding since it was founded in 2023.